BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34500749)

  • 21. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
    Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
    Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
    J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
    Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
    Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
    Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinspired imidazo[1,2-a:4,5-c']dipyridines with dual antiproliferative and anti-migrative properties in human cancer cells: The SAR investigation.
    Alzain AA; Brisson L; Delaye PO; Pénichon M; Chadet S; Besson P; Chevalier S; Allouchi H; Mohamed MA; Roger S; Enguehard-Gueiffier C
    Eur J Med Chem; 2021 Jun; 218():113258. PubMed ID: 33813152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells.
    Saito H; Tabata K; Hanada S; Kanda Y; Suzuki T; Miyairi S
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5370-3. PubMed ID: 21802947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
    Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic activity and influence on acetylcholinesterase of series dinuclear platinum(II) complexes with aromatic nitrogen-containing heterocyclic bridging ligands: Insights in the mechanisms of action.
    Bondžić AM; Žakula JJ; Korićanac LB; Keta OD; Janjić GV; Đorđević IS; Rajković SU
    Chem Biol Interact; 2022 Jan; 351():109708. PubMed ID: 34666020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.
    Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS
    Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
    Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
    J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors.
    Contreras JM; Parrot I; Sippl W; Rival YM; Wermuth CG
    J Med Chem; 2001 Aug; 44(17):2707-18. PubMed ID: 11495583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
    Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
    Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
    Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
    Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking.
    Ahmed EM; Khalil NA; Taher AT; Refaey RH; Nissan YM
    Bioorg Chem; 2019 Nov; 92():103272. PubMed ID: 31539742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.
    Basiri A; Xiao M; McCarthy A; Dutta D; Byrareddy SN; Conda-Sheridan M
    Bioorg Med Chem Lett; 2017 Jan; 27(2):228-231. PubMed ID: 27914796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and bioevaluation of 6-chloropyridazin-3-yl hydrazones and 6-chloro-3-substituted-[1,2,4]triazolo[4,3-b]pyridazines as cytotoxic agents.
    Mamta ; Aggarwal R; Sadana R; Ilag J; Sumran G
    Bioorg Chem; 2019 May; 86():288-295. PubMed ID: 30735849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.